Research sites play an important role in implementing diversity plans, reducing barriers to participation and improving patient retention with greater engagement. These were just a few important themes from the Society for Clinical Research Sites’ second Diversity Site Solutions Summit.
The latest omnibus bill includes legislation that will codify FDA guidelines for diversity in clinical trials into law. Learn more about what this means for sponsors.